Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Recruiting · NCT03774446 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease | ACTH-dependent Cushing syndrome, brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Recruiting | Phase 2 | 2025-09-11 | NCT03774446 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cedars-Sinai Medical Center | 161 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |